NVO Cash from Investing Activities - Cash Flow Statement - Novo Nordisk A/S - IntrinsicAlpha

Novo Nordisk A/S NVO

Healthcare - Drug Manufacturers - General - NYSE - DK

$ 90.65

1.6 %

$ 399 B

Market Cap

28.51

P/E

NVO - CASH FROM INVESTING ACTIVITIES

Cash from Investing Activities NVO - Novo Nordisk A/S

-129 B

LAST VALUE

-127.44%

2 YEAR CAGR

-62.12%

5 YEAR CAGR

-51.20%

10 YEAR CAGR